EORTC QLQ-C30 symptom components and their functional correlates during adjuvant chemotherapy for early breast cancer: a multivariate analysis. Data from GEICAM/2003-02 study.
Andrea Blasco, Roberto Pastor-Barriuso, Pilar Zamora-Auñón et al.
✦ AI-curated · Sources linked
In 30 seconds
This multivariate analysis of data from a multicentre phase III randomised trial examined changes in EORTC QLQ-C30 symptoms and their relationships with functioning among 820 patients with early breast cancer receiving adjuvant chemotherapy. Principal component analysis identified three symptom-change components, together explaining 53.6% of variance: general symptom burden, gastrointestinal symptoms, and diarrhea-specific symptoms. The general component, led by fatigue alongside pain, appetite loss, insomnia, nausea/vomiting and dyspnea, was negatively correlated with every functional scale and global health status. Network modelling also identified fatigue as the symptom most strongly connected to functional impairment.
Key findings
- Three symptom-change components explained 53.6% of variance: general symptom burden, gastrointestinal symptoms, and diarrhea-specific symptoms.
- The general symptom burden component was negatively correlated with all functional scales and global health status.
- Fatigue was the symptom most strongly connected to functional impairment in graphical LASSO network modelling.
- Patterns were similar across treatment arms, although gastrointestinal-related components differed.
Why it matters
Symptoms during chemotherapy may change together rather than act as isolated problems. Recognising a broader symptom-burden pattern, with fatigue central to its relationship with functional impairment, can help clinicians interpret patient-reported outcomes in context. The analysis also illustrates how multivariate methods can complement conventional questionnaire scoring when exploring treatment-related symptom patterns.
What to keep in mind
The analyses are exploratory and assess correlations, so they do not establish that particular symptoms cause functional decline or demonstrate that symptom-focused interventions improve outcomes.